Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01522703 · ClinicalTrials.gov registry record · NA
Effects of Whole Sprouts on Airway Allergic Inflammation
A NA study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 51
- Enrollment target
NCT01522703: Completed NA study, sponsored by Johns Hopkins University.
NCT01522703 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 51 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01522703, a NA study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 51 participants
- Enrollment target
Study Summary
The primary objective of this study is to determine if broccoli sprouts (BS) improves airway inflammatory, oxidative stress (OS), and symptoms among asthmatic adults with aeroallergen sensitization. The study is a double-blind, placebo-controlled, randomized trial to compare BS to placebo in 40 adults with asthma. 40 adults (age 18-50) who meet these eligibility criteria will be randomized to receive either: (a) BS or (b) placebo (alfalfa sprouts). Subjects will eat a sprouts sandwich daily for three days, and then undergo repeat measurement of outcomes.
Interventions
- DRUG Placebo
- DRUG Broccoli Sprouts
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2012-03 |
| Est. Completion | 2015-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01522703
The ClinicalTrials.gov registry entry for NCT01522703 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01522703 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01522703 about?
NCT01522703 is a clinical study titled "Effects of Whole Sprouts on Airway Allergic Inflammation". The primary objective of this study is to determine if broccoli sprouts (BS) improves airway inflammatory, oxidative stress (OS), and symptoms among asthmatic adults with aeroallergen sensitization. The study is a double-blind, placebo-controlled, randomized trial to compare BS to placebo in 40 adu...
What is the current status of trial NCT01522703?
This trial is currently completed. It is a NA study. The enrollment target is 51 participants. The study started on 2012-03. Estimated completion is 2015-03.
What interventions are being tested in trial NCT01522703?
The interventions under investigation include: Placebo (DRUG), Broccoli Sprouts (DRUG).
Who is sponsoring clinical trial NCT01522703?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.